Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use | ORKG Ask

We use cookies to provide a better user experience.

Data Protection

Related items

Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance

Smits, Rosanne M.
Veldhuijzen, Dieuwke S.
van Middendorp, Henriet
Muller, Petra C. E. Hissink
Armbrust, Wineke
Legger, Elizabeth
Wulffraat, Nico M.
Evers, Andrea W. M.

February 2020

Background: Methotrexate (MTX) therapy has proven to be a successful and safe treatment for Juvenile...

Methotrexate Monotherapy in Juvenile Idiopathic Arthritis Associated Uveitis: Myth or Reality?

Tirelli F.
Zannin M. E.
Vittadello F.
Agnolucci J.
Mazzarolo M.
Zulian F.

January 2021

Objective: To evaluate the long-term efficacy of methotrexate (MTX) monotherapy in patients with juv...

Impact of anti-inflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: Longitudinal analysis from a nation-wide paediatric rheumatological database

Tappeiner, Christoph
Schenck, Sandra
Niewerth, Martina
Heiligenhaus, Arnd
Minden, Kirsten
Klotsche, Jens

January 2015

PURPOSE Based on a nation-wide database, this study analysed the influence of methotrexate (MTX),...

Early methotrexate treatment in JIA-related uveitis

Piermarocchi, Stefano
M. E., Zannin1
A,
G., Martini1
A, B
E., Pilotto1
B,
F., Loro1
A,
F., Zacchello1
A,
F., Zulian1

January 2004

Purpose: The treatment of chronic uveitis in Juvenile Idiopathic Arthritis (JIA) is still a challeng...

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting

Giovanna Ferrara
Greta Mastrangelo
Patrizia Barone
Francesco La Torre
Silvana Martino
Giovanni Pappagallo
Angelo Ravelli
Andrea Taddio
Francesco Zulian
Rolando Cimaz
On behalf of the Rheumatology Italian Study Group

July 2018

Abstract Background Conventional pharmacological therapies for the treatment of juvenile idiopathic ...

A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)

Ramanan, Athimalaipet V
Dick, Andrew D
Benton, Diana
Compeyrot-Lacassagne, Sandrine
Dawoud, Dalia
Hardwick, Ben
Hickey, Helen
Hughes, Dyfrig
Jones, Ashley
Woo, Patricia
Edelsten, Clive
Beresford, Michael W

January 2014

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. Children with ...

Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance

Smits, Rosanne M.
Veldhuijzen, Dieuwke S.
van Middendorp, Henriet
Muller, Petra C. E. Hissink
Armbrust, Wineke
Legger, Elizabeth
Wulffraat, Nico M.
Evers, Andrea W. M.

February 2020

Background: Methotrexate (MTX) therapy has proven to be a successful and safe treatment for Juvenile...

Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting

Giovanna Ferrara
Greta Mastrangelo
Patrizia Barone
Francesco La Torre
Silvana Martino
Giovanni Pappagallo
Angelo Ravelli
Andrea Taddio
Francesco Zulian
Rolando Cimaz
On behalf of the Rheumatology Italian Study Group

July 2018

Abstract Background Conventional pharmacological therapies for the treatment of juvenile idiopathic ...

A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)

Ramanan, Athimalaipet V
Dick, Andrew D
Benton, Diana
Compeyrot-Lacassagne, Sandrine
Dawoud, Dalia
Hardwick, Ben
Hickey, Helen
Hughes, Dyfrig
Jones, Ashley
Woo, Patricia
Edelsten, Clive
Beresford, Michael W

January 2014

Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in children. Children with ...

Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance

Smits, Rosanne M.
Veldhuijzen, Dieuwke S.
van Middendorp, Henriet
Muller, Petra C. E. Hissink
Armbrust, Wineke
Legger, Elizabeth
Wulffraat, Nico M.
Evers, Andrea W. M.

February 2020

Background: Methotrexate (MTX) therapy has proven to be a successful and safe treatment for Juvenile...